Target Validation Information | |||||
---|---|---|---|---|---|
Target ID | T06037 | ||||
Target Name | mRNA of human Jun-N-terminal kinase-2 (JNK2) | ||||
Target Type | Research |
||||
Drug Potency against Target | N-(4-amino-6-butoxy-5-cyanopyridin-2-yl)acetamide | Drug Info | IC50 = 4663 nM | [528237] | |
N-(4-amino-5-cyano-6-phenylpyridin-2-yl)acetamide | Drug Info | Ki = 1900 nM | [528237] | ||
N-(4-amino-5-cyano-6-ethoxypyridin-2-yl)acetamide | Drug Info | Ki = 440 nM | [528237] | ||
AS-601245 | Drug Info | IC50 = 5000 nM | [529039] | ||
References | |||||
Ref 528237 | J Med Chem. 2006 Jun 15;49(12):3563-80.Aminopyridine-based c-Jun N-terminal kinase inhibitors with cellular activity and minimal cross-kinase activity. | ||||
Ref 528237 | J Med Chem. 2006 Jun 15;49(12):3563-80.Aminopyridine-based c-Jun N-terminal kinase inhibitors with cellular activity and minimal cross-kinase activity. | ||||
Ref 528237 | J Med Chem. 2006 Jun 15;49(12):3563-80.Aminopyridine-based c-Jun N-terminal kinase inhibitors with cellular activity and minimal cross-kinase activity. | ||||
Ref 529039 | Biochem J. 2007 Dec 15;408(3):297-315.The selectivity of protein kinase inhibitors: a further update. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.